Tarlatamab: Mechanism of Action and Clinical Success in Small Cell Lung Cancer │ Pharmacology
2:37
Elacestrant: A New Weapon Against Advanced Estrogen Receptor-Positive Breast Cancer
18:16
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
30:52
Taking a BiTE Out of SCLC
4:23
Zilucoplan Explained: How This New Drug Works for Myasthenia Gravis │ Pharmacology
20:58
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
4:11
Amivantamab Lazertinib Combo for Non-Small Cell Lung Cancer: Novel Mechanisms of Action
52:26
Harnessing the Power of the Latest Clinical and Research Advances in SCLC
59:56